Percentage of myeloid abnormalities detected by flow cytometry, N = 165
| Abnormality . | n (%) . |
|---|---|
| Lack of HLA-DR | 5 (3) |
| Decreased CD45 expression | 58 (35) |
| Lack or decreased CD34 | 13 (8) |
| Lack or decreased CD13 | 15 (9) |
| Lack or decreased CD33 | 21 (13) |
| Overexpression of CD34 | 14 (9) |
| Overexpression of CD13 | 9 (5) |
| Overexpression of CD33 | 3 (2) |
| Expression of CD56 | 7 (4) |
| Expression of lymphoid antigens | 16 (10) |
| Expression of CD11b | 4 (2) |
| Abnormality . | n (%) . |
|---|---|
| Lack of HLA-DR | 5 (3) |
| Decreased CD45 expression | 58 (35) |
| Lack or decreased CD34 | 13 (8) |
| Lack or decreased CD13 | 15 (9) |
| Lack or decreased CD33 | 21 (13) |
| Overexpression of CD34 | 14 (9) |
| Overexpression of CD13 | 9 (5) |
| Overexpression of CD33 | 3 (2) |
| Expression of CD56 | 7 (4) |
| Expression of lymphoid antigens | 16 (10) |
| Expression of CD11b | 4 (2) |